| Size & multiples | |||
| Market Cap | $429.1M | Enterprise Value | — |
| P/E (TTM) | 40.07× | PEG (trailing) | — |
| P/S | 0.46× | P/FCF | 144.91× |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | — | EV/FCF | — |
| FCF Yield | 0.69% | Buyback Yield | 3.54% |
| Owner Earnings (TTM) | $27.7M | Owner Earnings Yield | 6.46% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.71 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 7.54% |
| After-tax Cost of Debt | — | Synthetic credit rating | AAA |
| Cost of Debt · embedded (pre-tax) | — | Cost of Debt · marginal (synthetic) | 4.40% |
| WACC | — | ROIC | — |
| EVA Spread (ROIC−WACC) | — | EVA | — |
FCF sits 89% below owner earnings — spending above maintenance (growth capex) or absorbing working capital, so FCF understates the steady-state cash the business throws off.
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM $0.58 · revenue TTM $925.9M · FCF TTM $3.0M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Rich vs Health Care on P/E
P/E 76th percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| P/E | 40.1x | 24.4x | 13.0x–39.3x | 76 ↑rich |
| FCF Yield | 2.0% | -7.8% | -34.7%–1.4% | 77 ↑strong |
| Net Margin | 1.2% | -21.2% | -325.3%–7.2% | 66 ↑strong |
| Operating Margin | 4.0% | -34.5% | -552.0%–8.0% | 70 ↑strong |
| ROE | 2.0% | -36.8% | -92.5%–4.5% | 73 ↑strong |
